| HPV | Human Papilloma Virus |
|---|---|
| HRIG | Human Rabies Immuno-Globulin; ÀÎü ±¤°æº´ ¸é¿ª ±Û·ÎºÒ¸° |
| HSA | Human Serum Albumin |
| TIG: (human) Tetanus Immune(Immuno-) Globulin | ÆÄ»ódz Àΰ£ ¸é¿ª ±Û·ÎºÒ¸° |
| ADM | abductor digiti minimi; administrative medicine; admission; Adriamycin; Alcohol, Drug Abuse and Ment... |
| human ecology | The relations of persons to their total (biologic and social) environment. (05 Mar 2000) |
|---|---|
| human ehrlichiosis | A form of ehrlichiosis that presents clinically as a undifferentiated acute febrile illness characterised by fever, chills, diarrhoea, and headache, following tick bite(s), probably by the Lone Star Tick, Amblyomma americanum. Caused by Ehrlichia chaffeensis. First described in 1987. (Thought to be predominantly a monocytic form of ehrlichiosis.) (05 Mar 2000) |
| human embryo lung cell | <cell culture> Diploid, untransformed cells from the lungs of human embryos which are used to make vaccines against certain viruses (such as rabies). (09 Oct 1997) |
| human engineering | The science of designing, building or equipping mechanical devices or artificial environments to the anthropometric, physiological, or psychological requirements of the people who will use them. (12 Dec 1998) |
| human fibrin foam | A dry artificial sponge of human fibrin prepared by clotting with thrombin a foam of a solution of human fibrinogen; the clotted foam is dried from the frozen state and heated; used as a topical anticoagulant. (05 Mar 2000) |
| human gamma globulin | A preparation of the proteins of liquid human plasma, containing the antibodies of normal adults; it is obtained from pooled liquid human plasma from a number of donors and may be prepared by precipitation with organic solvents under controlled conditions of pH, ionic strength, and temperature. Synonym: human normal immunoglobulin. (05 Mar 2000) |
| human gene therapy | <molecular biology, technique> Insertion of normal DNA directly into cells to correct a genetic defect. (09 Oct 1997) |
| human genetics | The study of the genetic aspects of humans as a species. Compare: medical genetics. (05 Mar 2000) |
| human granulocytic ehrlichiosis | A form of ehrlichiosis in a patient with a history of tick bite. Characterised by leukopenia, thrombocytopenia, and mild liver damage. (Thought to be predominantly a granulocytic form of ehrlichiosis.) The species of Ehrlichia that is the agent of this disease is unknown at present. (05 Mar 2000) |
| human growth hormone | <endocrinology> A protein produced in the pituitary gland that stimulates the liver to produce somatomedins, which stimulate growth of bone and muscle. (09 Oct 1997) |
| human herpesvirus 1 | Herpes simplex virus, type 1. See: herpes simplex. (05 Mar 2000) |
| human herpesvirus 2 | Herpes simplex virus, type 2. See: herpes simplex. (05 Mar 2000) |
| human herpesvirus 3 | A herpesvirus, morphologically identical to herpes simplex virus, that causes varicella (chickenpox) and herpes zoster in man; varicella results from a primary infection with the virus; herpes zoster results from secondary invasion by the same virus or by reactivation of infection which in many instances has been latent for many years. Synonym: chickenpox virus, herpes zoster virus, human herpesvirus 3. (05 Mar 2000) |
| human herpesvirus 4 | <virology> Species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations. (27 Sep 1997) |
| human herpesvirus 5 | <virology> Probably the most widespread of the Herpetoviridae group. Infected cells enlarge and have a characteristic inclusion body (composed of virus particles) in the nucleus. Causes disease only in utero (leading to abortion or stillbirth or to various congenital defects), although can be opportunistic in the immunocompromised host. Patients who have been exposed to the virus will remain cytomegalovirus IgG positive. Acronym: CMV (30 Sep 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|